S100A4 and B-cell chronic lymphocytic leukemia: S100A4 gene expression was significantly stimulated after treatment with an inhibitor of the PI3K signaling pathway (Ly294002) in comparison to nontreated MNCs of CLL patients (p < 0.05, Figure 3A).